Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar captsteve66 (< 20) Submitted: 1/12/2011 9:48:25 AM : Outperform Start Price: $3.04 ASTM Score: -35.69

rated buy. cell structure is the future?

Featured Broker Partners


Advertisement